SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-010927
Filing Date
2020-07-30
Accepted
2020-07-30 08:11:49
Documents
3
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq22020earningsrele.htm 8-K 35302
2 EX-99.1 a991pressreleasedatedj.htm EX-99.1 145173
3 x4logo11.jpg GRAPHIC 9468
  Complete submission text file 0001628280-20-010927.txt   189424
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 201059300
SIC: 2836 Biological Products, (No Diagnostic Substances)